Fouad Namouni, PRESIDENT, R & D at Blueprint Medicines Corp (BPMC), sold 8,754 shares at $90.69 ($794K) on 2024-03-07, disclosed to the SEC on 2024-03-11.
Seasonal sale ($794k) by PRESIDENT, R & D — this insider has traded BPMC in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.69 | 4,377 | $397K | 50.0% |
| 2 | $90.69 | 4,377 | $397K | 50.0% |
| Total | $90.69 avg | 8,754 | $794K | 100% |
| Filing → |
| BPMC | SELL | 2023-10-05 | $362K | — | Filing → |
| BPMC | SELL | 2023-03-08 | $175K | — | Filing → |
| BPMC | SELL | 2022-10-05 | $468K | — | Filing → |